FzioMed Inc. Announces 300,000 Units of Oxiplex Sold
9/24/2012 9:48:28 AM
SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. (www.fziomed.com) announced that they have shipped the 300,000th unit of Oxiplex®. Oxiplex is approved outside of the United States in 68 countries worldwide and is distributed under the brand names Oxiplex®, Oxiplex®/SP and MediShield™. Oxiplex is an absorbable gel that is applied to spinal nerve roots during lumbar laminectomy, laminotomy and discectomy procedures. Oxiplex creates a temporary, protective barrier against the damaging effects of excessive fibrosis, inflammation and other irritants that can lead to recurrent postoperative pain. Oxiplex has been shown in numerous clinical studies to improve spine surgery outcomes by significantly reducing postoperative leg pain, back pain and neurological symptoms.
comments powered by